(Last updated : 2024-03-26 20:40:08)
  樋口 智昭
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine  Department of Internal Medicine, Division of Rheumatology
   Position   Endowed Assistant Professor
■ Published papers
1. Original article  Association of elevated serum carbohydrate antigen 19-9 levels with extensive interstitial lung disease in patients with systemic sclerosis: A cross-sectional study 2023/11/20
2. Original article  Antifibrotic effect of apremilast in systemic sclerosis dermal fibroblasts and bleomycin-induced mouse model 2023/11/08
3. Original article  Evaluation of RABBIT risk score in Japanese patients with rheumatoid arthritis starting first bDMARDs: a validation study using the IORRA cohort data. 2023/07/06
4. Original article  Evaluation of Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitis compared to ACR/EULAR 2022 classification criteria. 2023/06/03
5. Case report  A case of systemic lupus erythematosus having concurrent Evans syndrome and acquired thrombotic thrombocytopenic purpura. 2023/02/08
Display all(23)
■ Academic conference presentation
1. Causes and risk factors for death in Japanese systemic sclerosis  2024/03/14
2. Autoimmunity(FOXM1 regulates fibrotic activity of skin fibroblasts derived from patients with systemic sclerosis)  2022/11
3. Association study of IFIH1 gene polymorphisms in systemic sclerosis (SSc)  2022/04/25
4. MPO-ANCA POSITIVITY IS RELATED TO INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS  2018/06/15
5. Apremilast Attenuates the Fibrogenic Phenotype of Dermal Fibroblasts from Patients with Systemic Sclerosis, Contributing to the Prevention of the Progression of Experimental Dermal Fibrosis  2016/11/16
Display all(13)
■ Education
1. 2013/04~2017/03 〔Doctoral course〕, Graduate School, Division of Medicine, Tokyo Women's Medical University, Completed,